Article Details
Retrieved on: 2022-07-23 21:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca. Bayer. Pfizer. Novartis. Roche. The worldwide market for G-CSF Biosimilars is expected to grow at a CAGR of roughly xx% over the next ...
Article found on: thepost.nz
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here